Have a personal or library account? Click to login
Challenges in Identifying and Diagnosing Asbestos-Related Diseases in Emerging Economies: A Global Health Perspective Cover

Challenges in Identifying and Diagnosing Asbestos-Related Diseases in Emerging Economies: A Global Health Perspective

Open Access
|Sep 2025

References

  1. Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Health. 2014;80(4):257262. doi:10.1016/j.aogh.2014.09.016.
  2. International Agency for Research on Cancer. Asbestos Chrysotile, Amosite, Crocidolite, Tremolite, Actinolite, and Anthophyllite. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; 2012.
  3. Mossman BT. Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in vitro (cell or organ culture) models and bioassays. Regul Toxicol Pharmacol. 2008;52(Suppl):S200S203. doi:10.1016/j.yrtph.2007.10.004.
  4. The Lancet. Asbestos‑related disease—a preventable burden. Lancet. 2008;372(9654):1927. doi:10.1016/S0140-6736(08)61821-8.
  5. Sokolove Law. Anniversary of U.S. Asbestos Ban: 35 Years Later, Americans Still Lack Protections. Accessed July 11, 2025. https://www.sokolovelaw.com/blog/1989-usa-asbestos-ban-lifted-1991/.
  6. Wickramatillake BA, Fernando MA, Frank AL. Prevalence of asbestos‑related disease among workers in Sri Lanka. Ann Glob Health. 2019;85(1):108. doi:10.5334/aogh.2575.
  7. International Ban Asbestos Secretariat. Asbestos Profile: India. Accessed August 20, 2025. https://ibasecretariat.org/prof_india.php.
  8. International Labour Organization. Convention C162 ‑ Asbestos Convention, 1986 (No. 162). Accessed February 15, 2025. https://normlex.ilo.org/dyn/nrmlx_en/f?p=NORMLEXPUB:12100:0::NO::P12100_INSTRUMENT_ID:312307.
  9. Basel Convention. The Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and their. Accessed February 15, 2025. https://www.basel.int/theconvention/overview/tabid/1271/default.aspx.
  10. Lin RT, Chien LC, Jimba M, Furuya S, Takahashi K. Implementation of national policies for a total asbestos ban: A global comparison. Lancet Planet Health. 2019;3(8):e341e348. doi:10.1016/S2542-5196(19)30109-3.
  11. Schlünssen V, Mandrioli D, Pega F, et al. The prevalences and levels of occupational exposure to dusts and/or fibres (silica, asbestos and coal): A systematic review and meta‑analysis from the WHO/ILO joint estimates of the work‑related Burden of disease and injury. Environ Int. 2023;178:107980. doi:10.1016/J.ENVINT.2023.107980.
  12. Li N, Zhai Z, Zheng Y, et al. Association of 13 occupational carcinogens in patients with cancer, individually and collectively, 1990–2017. JAMA Netw Open. 2021;4(2):e2037530. doi:10.1001/jamanetworkopen.2020.37530.
  13. LaDou J, Castleman B, Frank A, et al. The case for a global ban on asbestos. Environ Health Perspect. 2010;118(7):897901. doi:10.1289/ehp.1002285.
  14. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6):691715. doi:10.1164/rccm.200310-1436ST.
  15. World Health Organization. Chemical Safety and Health. 2024. Accessed February 15, 2025. https://www.who.int/teams/environment-climate-change-and-health/chemical-safety-and-health/health-impacts/chemicals/asbestos.
  16. Odgerel C, Takahashi K, Sorahan T, et al. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. Occup Environ Med. 2017;74(12):851858. doi:10.1136/oemed-2017-104298.
  17. Singh R, Frank AL. Analysis of the Indian government’s position on the use of asbestos and its health effects. Public Health Action. 2023;13(2):5052. doi:10.5588/pha.23.0013.
  18. Ameille J, Brochard P, Brechot JM, et al. Pleural thickening: A comparison of oblique chest radiographs and high‑resolution computed tomography in subjects exposed to low levels of asbestos pollution. Int Arch Occup Environ Health. 1993;64(8):545548. doi:10.1007/BF00517698.
  19. Nishikawa K, Takahashi K, Karjalainen A, et al. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: A global assessment. Environ Health Perspect. 2008;116(12):16751680. doi:10.1289/ehp.11272.
  20. World Health Organization. WHO Global Plan of Action on Workers’ Health (2008‑2017): Baseline for implementation: Global country survey 2008/2009: Executive summary and survey findings. 2013. Accessed Aug 20, 2025. https://www.who.int/publications/i/item/WHO-FWC-PHE-2013-01.
  21. Singh R, Frank AL. Notification and recordkeeping of occupational mesothelioma in India. MedRxiv. February 14, 2025. doi:10.1101/2025.02.11.25322115.
  22. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: Comparison of diagnostic accuracy of CT and chest radiography. Radiology. 1989;171(1):111116. doi:10.1148/radiology.171.1.2928513.
  23. Manners D, Wong P, Murray C, et al. Correlation of ultra‑low dose chest CT findings with physiologic measures of asbestosis. Eur Radiol. 2017;27(8):34853490. doi:10.1007/s00330-016-4722-7.
  24. Lee YCG, Singh B, Pang SC, de Klerk NH, Hillman DR, Musk AW. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med. 2003;60(3):201206. doi:10.1136/oem.60.3.201.
  25. Ohar J, Sterling DA, Bleecker E, Donohue J. Changing patterns in asbestos‑induced lung disease. Chest. 2004;125(2):744753. doi:10.1378/chest.125.2.744.
  26. Miller A. Pulmonary function in asbestosis and asbestos‑related pleural disease. Environ Res. 1993;61(1):118. doi:10.1006/enrs.1993.1044.
  27. Baur X. Asbestos‑related disorders in Germany: Background, politics, incidence, diagnostics and compensation. Int J Environ Res Public Health. 2018;15(1):143. doi:10.3390/ijerph15010143.
  28. Lerman Y, Seidman H, Gelb S, Miller A, Selikoff IJ. Spirometric abnormalities among asbestos insulation workers. J Occup Med. 1998;30(3):228233.
  29. Brodkin CA, Barnhart S, Anderson G, Checkoway H, Omenn GS, Rosenstock L. Correlation between respiratory symptoms and pulmonary function in asbestos‑exposed workers. Am Rev Respir Dis. 1993;148:3237. doi:10.1164/ajrccm/148.1.32.
  30. Wright GW. Functional abnormalities of industrial pulmonary fibrosis. AMA Arch Ind Health. 1955;11:196203.
  31. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA. 1964;188(1):2226. doi:10.1001/jama.1964.03060270028006.
  32. Bader ME, Bader RA, Selikoff IJ. Pulmonary function in asbestosis of the lung. Am J Med. 1961;30:235242. doi:10.1016/0002-9343(61)90095-X.
  33. International Labour Organization. 2022 Revised edition of the ILO international classification of radiographs of Pneumoconioses. 2023. Accessed August 21, 2025. https://www.ilo.org/resource/news/2022-revised-edition-ilo-international-classification-radiographs.
  34. Roberts HC. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol. 2009;4(5):620628. doi:10.1097/JTO.0b013e31819f2e0e.
  35. Reid A, Alfonso H, Ti JSS, Wong E, de Klerk N, Musk AW. Sense of control and wellbeing decades after exposure to blue asbestos at wittenoom, Western Australia. Int J Occup Environ Health. 2012;18:116123. doi:10.1179/1077352512Z.0000000006.
  36. Musk AW, Kler KH, Ambrosini GL, et al. Vitamin A and cancer prevention I: Observations in workers previously exposed to asbestos at Wittenoom, Western Australia. Int J Cancer. 1998;75:355361. doi:10.1002/(sici)1097-0215(19980130)75:3<;355::aid-ijc5>3.0.co;2-1.
  37. Henderson DW, Jones ML, Klerk ND, et al. The diagnosis and attribution of asbestos‑related diseases in an Australian context: Report of the adelaide workshop on asbestos‑related diseases. October 6–7, 2000. Int J Occup Environ Health. 2004;10:4046. doi:10.1179/oeh.2004.10.1.40.
  38. Schuhmann M, Brims F, O’Reilly KMA. Asbestos‑related lung disease an update. Clin Pulm Med. 2011;18:265273. doi:10.1097/CPM.0b013e318235181f.
  39. Whitaker D. The cytology of malignant mesothelioma. Cytopathology. 2000;11:139151. doi:10.1046/j.1365-2303.2000.00247.x.
  40. Walker‑Bone K, Hollick R. Health and work: What physicians need to know. Clin Med (Lond). 2021;21:195200. doi:10.7861/clinmed.2020-0847.
  41. Alex R, Francis M, Prashanth HR, Kundavaram A. Occupational history: A neglected component of history taking. Indian J Occup Environ Med. 2013;17:2930. doi:10.4103/0019-5278.116371.
  42. Supernova Rotecting Your World. Can Lung Cancer Caused by Asbestos Exposure be Misdiagnosed or Mistaken for Other Types of Lung Cancer? – Understanding the Risk and Implications. 2023. Accessed August 21, 2025. https://asbestos-surveys.org.uk/asbestos/the-link-between-asbestos-and-lung-cancer/can-lung-cancer-caused-by-asbestos-exposure-be-misdiagnosed-or-mistaken-for-other-types-of-lung-cancer/.
  43. Roy p, Bardhan M, Roy S, Singh U, Suresh T, Anand A. Silico‑tuberculosis amidst COVID‑19 pandemic: Global scenario and Indian perspective. Ann Med Surg (Lond). 2023;84:60836090. doi:10.1097/MS9.0000000000001471.
  44. Lee G, Jeong YJ, Kim KI, et al. Comparison of chest digital tomosynthesis and chest radiography for detection of asbestos‑related pleuropulmonary disease. Clin Radiol. 2013;68(4):376382. doi:10.1016/j.crad.2012.05.022.
  45. Lamote K, Brinkman P, Vandermeersch L, et al. Breath analysis by gas chromatography‑mass spectrometry and electronic nose to screen for pleural mesothelioma: A cross‑sectional case‑control study. Oncotarget. 2017;8(53):9159391602. doi:10.18632/oncotarget.21335.
  46. Smallwood N, Dachsel M. Point‑of‑care ultrasound (POCUS): Unnecessary gadgetry or evidence‑based medicine? Clin Med (Lond). 2018;18:219224. doi:10.7861/clinmedicine.18-3-219.
  47. Smargiassi A, Pasciuto G, Pedicelli I, et al. Chest ultrasonography in health surveillance of asbestos‑related lung diseases. Toxicol Ind Health. 2017;33:537546. doi:10.1177/0748233716686916.
  48. Shah S, Umulisa I, Noble VE, et al. Development of an ultrasound training curriculum in a limited resource international setting: Successes and challenges of ultrasound training in rural Rwanda. Int J Emerg Med. 2008;1:193196. doi:10.1007/s12245-008-0053-z.
  49. Brusselmans L, Arnouts L, Millevert C, Vandersnickt J, van Meerbeeck JP, Lamote K. Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: A systematic review. Transl Lung Cancer Res. 2018;7:520536. doi:10.21037/tlcr.2018.04.09.
DOI: https://doi.org/10.5334/aogh.4871 | Journal eISSN: 2214-9996
Language: English
Submitted on: Jul 10, 2025
Accepted on: Aug 24, 2025
Published on: Sep 18, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Priyanka Roy, Ankita Raheja, Khushi Prajapati, Shubhajeet Roy, Mainak Bardhan, Arthur L. Frank, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.